Table 1.
Breast cell lines examined for paralemmin-1 mRNA and protein expression
|
Cell Line |
Donor Age |
Pathology |
ER |
Paralemmin-1 Expression |
|
|---|---|---|---|---|---|
| RNA | Protein (kDa) | ||||
| MCF-7 |
69 |
IDC |
Pos |
medium |
65, 55 |
| T47D |
54 |
IDC |
Pos |
low |
65* |
| ZR-75-1 |
47 |
IDC |
Pos |
medium |
65*, 55 |
| BT-20 |
74 |
IDC |
Neg1 |
low |
65, 55 |
| TMX2-284 |
69 |
IDC |
Neg |
high |
65, 55 |
| MDA-MB-231 |
51 |
Adeno |
Neg |
low |
none |
| MCF-10A |
36 |
NE |
Neg |
medium |
65 |
| 1842 |
15-66 |
NE |
Neg |
low |
none |
| 184A13 |
15-66 |
NE |
Neg |
low |
none |
| 184AA23 | 15-66 | NE | Neg | low | none |
1BT-20 cells express ER mRNA, but do not express ER protein; 2Non-tumorigenic mammary cell line from Dr. Martha Stamfer’s Laboratory 3Derivative of 184 cells; 4Derivative of MCF-7 cells IDC: Invasive ductal carcinomas Adeno: Adenocarcinoma; NE: Normal epithelial; Sources: [6-8]; *indicates a faint band.